NJ State Employees Deferred Compensation Plan’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-12,500	Closed	-$287K	–	436
2013 Q3	$287K	Hold	12,500	–	–	0.06%	346
2013 Q2	$221K	Buy	+12,500	New	+$221K	0.05%	358